Stepan Company account plan
Chemical product manufacturer
At a glance
Stepan Company makes surfactants, polymers and specialty chemicals for other manufacturers, with FY2025 net sales of $2,332.1 million.
Stepan Company (NYSE: SCL), headquartered in Northbrook, Illinois, produces specialty and intermediate chemicals sold to other manufacturers, never to retail: surfactants for cleaning, disinfection, personal care, agricultural and oilfield uses, polyurethane polyols for insulation and CASE, and food and pharmaceutical ingredients. FY2025 net sales were $2,332.1 million (+7%), net income $46.9 million and adjusted EBITDA $198.9 million. About 44% of net sales are made outside the United States, with large operations in France, the UK, Mexico, Brazil and Poland. It employed 2,328 people at December 31, 2025.
Business units
Surfactants
71% of 2025 consolidated net salesSurface-active agents for laundry, dish and household cleaning, shampoos and body washes, disinfectants, agricultural emulsifiers, oilfield and industrial uses, made at sites in the US, Europe, Latin America and Singapore. Led by Sean T. Moriarty. 2025 operating income fell 21% on Pasadena start-up costs and oleochemical costs; Q3 2026 net sales were $486.6 million (+15%) and operating income rose 75%.
Polymers
25% of 2025 consolidated net salesPolyurethane polyols for rigid foam insulation and CASE, polyester resins and phthalic anhydride, made in the US, Germany, the Netherlands, Poland and Nanjing, China. Led by Richard F. Stepan. Q3 2026 net sales rose 24% to $178.7 million, with North American volume up 18% while Europe fell on weak construction.
Specialty Products
4% of 2025 consolidated net salesFlavors, emulsifiers and solubilizers for food, nutritional supplement and pharmaceutical applications, mainly made in Maywood, New Jersey. Growth comes from medium chain triglycerides (MCT); Q3 2026 net sales were $26.9 million (+12%).
Strategic priorities
- Project Catalyst savings
- Announced in February 2026, the plan targets approximately $100.0 million of pre-tax savings over two years; the CEO now sees $66-70 million of savings in 2026 and more than $25 million per quarter on average in 2027.
- Footprint optimisation
- Fieldsboro, New Jersey was closed and assets at Millsdale and Stalybridge (UK) decommissioned, consolidating surfactant production into better-utilised sites, after the 2025 Philippines and Lake Providence divestitures.
- Tier 2/3 customers and diversification
- Year to date in 2026 Surfactants won more than 300 new customers and nearly 900 new customer-product combinations; the Tier 2/3 base grows double digits, alongside crop productivity, oilfield and sulfate-free personal care.
- Ramp up the Pasadena alkoxylation plant
- The Pasadena, Texas facility started up in April 2025 and runs at 75%-80% utilisation, with full utilisation expected in 2027; it is described as a critical enabler for specialty alkoxylates.
- Free cash flow and deleveraging
- Management targets positive free cash flow and continued deleveraging in 2026; net leverage was 2.4x in Q3 2026.
Latest results
In Q3 2026 (quarter to September 30, 2026) net sales rose 17% to $692.2 million on higher selling prices and 3% more volume, with organic volume up 7%. Net income was $17.8 million ($0.78 per diluted share) versus $10.8 million, and adjusted EBITDA rose 18% to $66.3 million, with growth in all three segments. Over nine months Stepan posted a net loss of $0.7 million because of $56.6 million of after-tax restructuring charges, while adjusted EBITDA rose 15% to $190.3 million. Management expects full-year adjusted EBITDA growth, positive free cash flow and further deleveraging in 2026.
Investments and deals
- Project Catalyst restructuring
- Restructuring expense was $76.1 million in the first nine months of 2026, with $77.0-80.0 million expected for the year, including about 100 salaried role cuts (7% of global salaried headcount).
- Capital expenditure
- Capex was $122.5 million in 2025; 2026 capex is now estimated at $100.0-105.0 million.
- New credit agreement
- A $500.0 million credit agreement maturing September 25, 2031 was signed on September 25, 2026, replacing the $450.0 million facility.
- Divestitures and land sale
- The Philippines (sold to Masurf) and Lake Providence, Louisiana assets were sold in Q4 2025; a parcel of land near Millsdale was sold in October 2026 for $28.5 million, all to pay down debt.
Challenges and risks
- Raw material and energy volatility
- Petroleum- and plant-based raw material costs remain volatile, including disruption linked to the Middle East conflict; higher oleochemical costs weighed on 2025 surfactant results.
- Weak Europe and China polymers demand
- European polymer volume fell 13% in Q3 2026 on weak construction, and management calls Europe and China a macro story.
- Working capital and debt
- Working capital consumed $99.0 million in nine months of 2026 and net debt rose to $536.0 million from $494.0 million.
- Environmental liabilities
- Remediation at the Maywood, NJ Superfund site and other sites, plus a USEPA notice of air violations at Millsdale, are named risks; higher Maywood remediation estimates raised Q3 2026 expenses.
- Tariffs and soft consumer demand
- Tariffs had an unexpected impact in 2025 and 2026 is expected to be as volatile; consumer surfactant demand was soft in 2025, with lower commodity laundry demand behind the Fieldsboro closure.
What leadership says
“Project Catalyst is not a short-term cost reduction program alone. It is a strategic transformation”
“Quarterly earnings were up significantly, driven by improved results in all three segments”
“We believe we are positioned to continue delivering growth and executing on our diversification strategy.”
Where a supplier can help
- Procurement and manufacturing productivity
- Project Catalyst's operational efficiency lever (procurement, manufacturing and logistics productivity, an enterprise-wide operating system) opens doors for procurement, plant reliability and logistics suppliers.
- Tools to serve Tier 2/3 customers
- Growth with smaller customers, which the CEO says is helped by automation, systems and tools, fits CRM, e-commerce and sales automation offers.
- Raw material risk management
- Volatile petroleum and oleochemical costs make commodity hedging, sourcing analytics and alternative feedstock suppliers relevant.
- Environmental remediation and compliance
- The Maywood and Millsdale environmental matters and recurring environmental operating costs point to remediation, emissions monitoring and compliance services.
- Site decommissioning and consolidation
- The Fieldsboro closure and decommissioning at Millsdale and Stalybridge create work for decommissioning, engineering and asset disposal services.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Stepan Company?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Stepan Company Annual Report on Form 10-K for fiscal year 2025
- Stepan Company (NYSE: SCL, Northbrook, Illinois) makes specialty and intermediate chemicals sold to other manufacturers, never to retail, in three segments: Surfactants (71% of 2025 net sales), Polymers (25%) and Specialty Products (4%). It calls itself one of the leading merchant producers of surfactants in the world.
- FY2025 net sales were $2,332.1 million, up 7%, driven by $130.7 million of higher selling prices (pass-through of raw materials and mix); sales volume rose 1% (2% excluding the Philippines divestiture).
- Net income fell 7% to $46.9 million ($2.05 per diluted share); adjusted net income was $41.7 million. EBITDA rose 11% to $208.0 million and adjusted EBITDA 6% to $198.9 million.
- Surfactant operating income fell 21% to $67.4 million as North American gross profit dropped 20% on the start-up of the new Pasadena, Texas alkoxylation facility and higher oleochemical costs; Polymers rose 7% and Specialty Products 23% on medium chain triglycerides (MCT) volume.
- About 44% of net sales are made outside the United States (France, UK, Mexico, Brazil, Poland the largest); the company employed 2,328 people at December 31, 2025.
- Footprint optimisation: SPQI assets in the Philippines sold to Masurf (Musim Mas) and the Lake Providence, Louisiana assets sold in Q4 2025 (gains $5.1 million and $10.8 million).
- In February 2026 it announced Project Catalyst, targeting approximately $100.0 million of pre-tax savings over two years; the board approved closing Fieldsboro, New Jersey and decommissioning assets at Millsdale and Stalybridge (UK), with $70-80 million of restructuring expense expected in 2026.
- Net debt fell to $494.0 million from $525.7 million; 2026 capex is estimated at $100.0-110.0 million (2025: $122.5 million). Key risks: raw material and energy volatility, plant accidents, tariffs and trade policy, environmental liabilities (Maywood, NJ Superfund site) and debt covenants.
- Stepan Company Form 10-Q for the quarter ended September 30, 2026
- Q3 2026 (quarter to September 30, 2026) net sales were $692.2 million, up 17%, on $76.8 million of higher selling prices (raw material pass-through and pricing actions) and 3% more volume; organic volume rose 7%.
- Q3 net income $17.8 million ($0.78 per diluted share) versus $10.8 million; adjusted net income $21.7 million ($0.94); adjusted EBITDA $66.3 million, up 18%.
- Surfactants operating income rose 75% to $27.4 million; Latin American surfactant sales jumped 39% on 21% more volume, North America rose 15%; Asia fell 66% after the Philippines divestiture.
- Polymers sales rose 24% with North American volume up 18% (rigid foam polyols +23%, phthalic anhydride +15%, spray foam double digits); Europe volume fell 13% on weak construction and a mandated maintenance turnaround in Germany.
- Nine months: net loss of $0.7 million because of $56.6 million of after-tax restructuring charges; adjusted net income $59.1 million ($2.58); adjusted EBITDA $190.3 million, up 15%.
- Project Catalyst: Fieldsboro (NJ) closed and assets at Millsdale and Stalybridge (UK) decommissioned; about 100 salaried roles (7% of global salaried headcount) cut in Q3; $76.1 million of restructuring expense year to date, $77.0-80.0 million expected for 2026.
- Working capital consumed $99.0 million in nine months; net debt rose to $536.0 million. A new $500.0 million credit agreement maturing in 2031 was signed on September 25, 2026; 2026 capex now estimated at $100.0-105.0 million.
- Stepan Reports Third Quarter 2026 Results (press release, Exhibit 99.1)
- Stepan's Q3 2026 results release (October 28, 2026): net sales $692.2 million, up 17%; adjusted EBITDA $66.3 million, up 18%; adjusted net income $21.7 million, up 98%.
- Global sales volume +3%, organic volume +7%; nine-month organic volume +4%.
- Surfactant adjusted EBITDA up 27% on volume growth and margin recovery, with double-digit growth in Consumer Products, Construction & Industrial, Oilfield and the Tier 2/3 customer base, offset partly by lower Crop Productivity demand.
- Polymer adjusted EBITDA up 4% despite the five-yearly maintenance turnaround in Germany; North American rigid, spray foam and phthalic anhydride volume up double digits.
- Specialty Products volume +20%, adjusted EBITDA +5% on medium chain triglycerides.
- Q3 free cash flow $8.2 million (operating cash $29.3 million, capex $21.1 million), hurt by working capital; a parcel of land near Millsdale was sold in October for $28.5 million, all to pay down debt.
- Restructuring: $5.6 million in Q3, including about 100 salaried position reductions (7% of global salaried headcount); $76.1 million year to date, with about $12.8 million of cash impact.
- Outlook: CEO Luis E. Rojo expects full-year adjusted EBITDA growth, positive free cash flow and further de-leveraging in 2026.
- Stepan (SCL) Q3 2026 Earnings Call Transcript
- Q3 2026 earnings call (October 28, 2026), CEO Luis E. Rojo with CFO Ruben Velasquez: adjusted EBITDA $66.3 million, up 18%, with organic volume up 7% and growth in all three segments.
- Strategy rests on four pillars: customer-centric innovation, diversification toward higher-growth end markets and Tier 2/3 accounts, operational excellence, and financial strength (free cash flow, deleveraging).
- Year to date: more than 300 new surfactant customers and nearly 900 new customer-product combinations; the Tier 2/3 customer base grows double digits.
- Project Catalyst savings ran at about $23 million in Q3; Rojo now sees $66-70 million of 2026 savings versus a $60 million target, and more than $25 million per quarter on average in 2027.
- The organizational redesign phase is done; restructuring in Q3 included a 7% reduction of global salaried headcount.
- Pasadena, Texas runs at 75%-80% utilisation and is "a critical enabler" for growth in specialty alkoxylates; tolling savings exceed plan.
- North American polymers grow strong double digits (rigid polyols, spray foam, phthalic anhydride); Europe and China remain weak, a "macro story", though Rojo sees pent-up European insulation demand over 3 to 5 years.
- Net leverage improved to 2.4x; net debt $536 million; a $28.5 million land sale near Millsdale goes to debt paydown. Guidance: full-year adjusted EBITDA growth, positive free cash flow and continued deleveraging in 2026.
- Stepan (SCL) Q4 2025 Earnings Call Transcript
- Q4 and full-year 2025 earnings call (February 2026), CEO Luis E. Rojo with CFO Ruben Velasquez: Rojo called 2025 "a transformational year for Stepan", with two plants divested and the best safety results in its history.
- 2025 adjusted EBITDA $199 million, up 6%; organic volume +2% on crop productivity, oilfield, tier two and three customers, polymers and specialty products, offset by soft consumer surfactants; leverage down from 2.8x to 2.5x.
- Project Catalyst launched: around $100 million of pre-tax savings over two years, about 60% in 2026, through footprint optimisation, operational efficiency and procurement, and organizational effectiveness.
- Closure of Fieldsboro, New Jersey (lower demand for commodity laundry surfactants) and decommissioning of alkoxylation assets at Millsdale and of a low-margin organics business at Stalybridge (UK), all in Surfactants.
- Pasadena alkoxylation plant commissioned; utilisation seen at around 70% to 80% in 2026 and full in 2027.
- 2026: adjusted EBITDA growth and positive free cash flow expected, weighted to the second half (oleochemical relief, Catalyst savings, demand recovery); about $6 million of Q1 EBITDA lost to a historic winter.
- Growth bets: tier two and three customers (mid single-digit growth in 2025), sulfate-free personal care, crop productivity and oilfield; capex guided at $105 million to $115 million.
Questions about Stepan Company
What does Stepan Company do?
Stepan makes specialty and intermediate chemicals for other manufacturers: surfactants for cleaning, personal care, agricultural and oilfield products, polyols for insulation and coatings, and ingredients for food and pharmaceuticals.
What is Stepan's revenue?
FY2025 net sales were $2,332.1 million, up 7%, with net income of $46.9 million. Q3 2026 net sales were $692.2 million.
How many employees does Stepan have?
Stepan employed 2,328 people at December 31, 2025.
Who leads Stepan Company?
Luis E. Rojo has been President and CEO since October 2024; Ruben D. Velasquez has been CFO since July 2025.
What is Project Catalyst?
An operational and efficiency plan announced in February 2026 targeting approximately $100.0 million of pre-tax savings over two years through site consolidation, procurement and organizational redesign.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)